These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39278311)

  • 1. NVP-BHG712 alleviates ovariectomy-induced osteoporosis by modulating osteoclastogenesis.
    Liu X; Liu S; Sun H; Zhang J; Li M; Shi Y; Wang G; Chen W; Cao Y; Lu G; Ning Y; Zhao Y
    Eur J Pharmacol; 2024 Nov; 983():177000. PubMed ID: 39278311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
    J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kim JH; Shin H; Kim M; Kim S; Song K; Jung HS; Sohn Y
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis.
    Chen X; Zhi X; Pan P; Cui J; Cao L; Weng W; Zhou Q; Wang L; Zhai X; Zhao Q; Hu H; Huang B; Su J
    FASEB J; 2017 Nov; 31(11):4855-4865. PubMed ID: 28739641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel anti-osteoporotic agent that protects against postmenopausal bone loss by regulating bone formation and bone resorption.
    Yang YT; Meng JH; Hu B; Ma CY; Zhao CC; Teng WS; Hong JQ; Li SH; Jiang GY; Wang C; Zhou CH; Yan SG
    Life Sci; 2018 Sep; 209():409-419. PubMed ID: 30096387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anacardic acid inhibits RANKL-induced osteoclastogenesis
    Zhao K; Jia Y; Peng J; Pang C; Zhang T; Han W; Jiang J; Lu X; Zhu J; Qian Y
    FASEB J; 2019 Aug; 33(8):9100-9115. PubMed ID: 31050917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.
    Cheng J; Zhou L; Liu Q; Tickner J; Tan Z; Li X; Liu M; Lin X; Wang T; Pavlos NJ; Zhao J; Xu J
    J Cell Physiol; 2018 Mar; 233(3):2502-2512. PubMed ID: 28771720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways.
    Xiao L; Zhong M; Huang Y; Zhu J; Tang W; Li D; Shi J; Lu A; Yang H; Geng D; Li H; Wang Z
    Aging (Albany NY); 2020 Nov; 12(21):21706-21729. PubMed ID: 33176281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
    Cheon YH; Lee CH; Kim S; Park GD; Kwak SC; Cho HJ; Kim JY; Lee MS
    Biomed Pharmacother; 2021 Jul; 139():111697. PubMed ID: 34243614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-κB activated pyroptosis pathways.
    Tao H; Li W; Zhang W; Yang C; Zhang C; Liang X; Yin J; Bai J; Ge G; Zhang H; Yang X; Li H; Xu Y; Hao Y; Liu Y; Geng D
    Pharmacol Res; 2021 Dec; 174():105967. PubMed ID: 34740817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phlpp1 is induced by estrogen in osteoclasts and its loss in Ctsk-expressing cells does not protect against ovariectomy-induced bone loss.
    Hanson MK; Karkache IY; Molstad DHH; Norton AA; Mansky KC; Bradley EW
    PLoS One; 2021; 16(6):e0251732. PubMed ID: 34143773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis.
    Kim M; Kim HS; Kim JH; Kim EY; Lee B; Lee SY; Jun JY; Kim MB; Sohn Y; Jung HS
    BMC Complement Med Ther; 2020 Feb; 20(1):35. PubMed ID: 32024503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anethole inhibits RANKL-induced osteoclastogenesis by downregulating ERK/AKT signaling and prevents ovariectomy-induced bone loss in vivo.
    Qu H; Zhang Y; He R; Lin N; Wang C
    Int Immunopharmacol; 2021 Nov; 100():108113. PubMed ID: 34530203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalpol attenuates osteoporosis in ovariectomized rats through promoting osteoclast apoptosis via the Sirt6-ERα-FasL axis.
    Chen S; Jin J; Xu Z; Han H; Wu L; Li Z
    Phytomedicine; 2024 Jan; 123():155262. PubMed ID: 38100921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity.
    Lin X; Yuan G; Yang B; Xie C; Zhou Z; Liu Y; Liu Z; Wu Z; Akimoto Y; Li N; Xu R; Song F
    Phytomedicine; 2024 Jul; 129():155559. PubMed ID: 38579642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.
    Chen W; Zhu G; Tang J; Zhou HD; Li YP
    J Pathol; 2018 Mar; 244(3):271-282. PubMed ID: 29083488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways.
    Yin Z; Zhu W; Wu Q; Zhang Q; Guo S; Liu T; Li S; Chen X; Peng D; Ouyang Z
    Eur J Pharmacol; 2019 Sep; 859():172550. PubMed ID: 31323222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ellagic acid protects ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption.
    Lin X; Yuan G; Li Z; Zhou M; Hu X; Song F; Shao S; Fu F; Zhao J; Xu J; Liu Q; Feng H
    J Cell Physiol; 2020 Sep; 235(9):5951-5961. PubMed ID: 32026468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NF-κB and ERK signaling pathways in osteoclasts and M1 macrophage polarization: Mechanistic insights into the anti-osteoporotic effects of Pseudolaric acid B.
    Liu L; Xiang C; Li T; Zhao Z; Xiao T; Ouyang Z
    Life Sci; 2024 May; 345():122592. PubMed ID: 38554947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bu-Shen-Tong-Luo decoction prevents bone loss via inhibition of bone resorption and enhancement of angiogenesis in ovariectomy-induced osteoporosis of rats.
    Yuan H; Xiao L; Min W; Yuan W; Lu S; Huang G
    J Ethnopharmacol; 2018 Jun; 220():228-238. PubMed ID: 29317302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.